CELLECT BIOTECHNOLOGY LTD's ticker is APOP and the CUSIP is 15116C201. A total of 7 filers reported holding CELLECT BIOTECHNOLOGY LTD in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $433,000 | +3.6% | 115,564 | -13.3% | 0.00% | 0.0% |
| Q1 2021 | $418,000 | +30.6% | 133,264 | -9.9% | 0.00% | – |
| Q4 2020 | $320,000 | -31.3% | 147,925 | -33.4% | 0.00% | – |
| Q3 2020 | $466,000 | -46.3% | 222,094 | -19.4% | 0.00% | -100.0% |
| Q2 2020 | $868,000 | +215.6% | 275,494 | +47.0% | 0.00% | – |
| Q1 2020 | $275,000 | +21.1% | 187,394 | +83.0% | 0.00% | – |
| Q4 2019 | $227,000 | – | 102,394 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Renaissance Technologies | 115,564 | $433,000 | 0.00% |
| UBS Group AG | 8,213 | $31,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 10,200 | $38,000 | 0.00% |
| MORGAN STANLEY | 5,252 | $20,000 | 0.00% |
| Citadel Advisors | 16,034 | $60,000 | 0.00% |
| HRT FINANCIAL LP | 13,049 | $48,000 | 0.00% |